Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| |  Online-Ressource |
|---|
| Verfasst von: | Rosendahl, Sophie [VerfasserIn]  |
|---|
| | Trudzinski, Franziska [VerfasserIn] |
|---|
| | Polke, Markus [VerfasserIn] |
|---|
| | Herth, Felix [VerfasserIn] |
|---|
| | Kreuter, Michael [VerfasserIn] |
|---|
| | Giese, Thomas [VerfasserIn] |
|---|
| Titel: | SARS-CoV-2 vaccination in primary humoral immunodeficiency |
|---|
| Titelzusatz: | experience from a german lung clinic |
|---|
| Verf.angabe: | Sophie Rosendahl, Franziska C. Trudzinski, Markus Polke, Felix J.F. Herth, Michael Kreuter, Thomas Giese |
|---|
| E-Jahr: | 2025 |
|---|
| Jahr: | May 2025 |
|---|
| Umfang: | 11 S. |
|---|
| Fussnoten: | Veröffentlicht: 19. Dezember 2024 ; Gesehen am 25.07.2025 |
|---|
| Titel Quelle: | Enthalten in: Respiration |
|---|
| Ort Quelle: | Basel : Karger, 1968 |
|---|
| Jahr Quelle: | 2025 |
|---|
| Band/Heft Quelle: | 104(2025), 5 vom: Mai, Seite 349-359 |
|---|
| ISSN Quelle: | 1423-0356 |
|---|
| Abstract: | Introduction: During the COVID-19 pandemic, the effectiveness of vaccines against SARS-CoV-2 in immunodeficient patients not only did affect the individual risk of these vulnerable patients but endangered the selection of new variants of concern due to prolonged virus shedding by these patients. Methods: In a tertiary center for pulmonary diseases, we investigated the immune response of 11 patients with primary humoral immunodeficiency and 13 healthy controls on the humoral and cellular level after full vaccination with an mRNA or vector vaccine against SARS-CoV-2. Results: In the majority of patients (73%), we found antibodies against the spike protein above the threshold of positivity. Likewise, patients showed a promising cellular response: the upregulated production of INFγ, TNFα, and CXCL10 by T cells did not differ from the response of healthy controls. Conclusion: These results stress the importance to further discern an adequate immunological correlate of protection and the need to follow the effect of booster immunizations in this population at risk. |
|---|
| DOI: | doi:10.1159/000543146 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1159/000543146 |
|---|
| | DOI: https://doi.org/10.1159/000543146 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1931798087 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
SARS-CoV-2 vaccination in primary humoral immunodeficiency / Rosendahl, Sophie [VerfasserIn]; May 2025 (Online-Ressource)
69368957
